CHARLOTTE FULLER: Open Payments
NPI 1033657580 · MANDEVILLE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$515 in 24 payments from 7 companies in 2025. Trend: 2023 $435 · 2024 $517 · 2025 $515
Food & beverage: $515
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $216 |
| Amgen Inc. | 9 | $151 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| ABBVIE INC. | 2 | $31 |
| Vanda Pharmaceuticals Inc. | 1 | $29 |
| Acrotech Biopharma Inc. | 1 | $27 |
| Exact Sciences Corporation | 1 | $24 |
Products named: BREZTRI, REPATHA, CAPLYTA, AIRSUPRA, VRAYLAR, FANAPT, BELEODAQ, OTEZLA.
Industry payments across LA — which companies pay providers there.
